ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients

ClinicalTrials.gov ID: NCT03150420

Public ClinicalTrials.gov record NCT03150420. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 5:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Intravenous Sodium Thiosulfate for Acute Calciphylaxis Treatment: A Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Trial

Study identification

NCT ID
NCT03150420
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hope Pharmaceuticals
Industry
Enrollment
29 participants

Conditions and interventions

Conditions

Interventions

  • Placebo-Normal Saline Drug
  • Sodium Thiosulfate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 23, 2017
Primary completion
Apr 14, 2020
Completion
Apr 14, 2020
Last update posted
May 18, 2020

2017 – 2020

United States locations

U.S. sites
12
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
Mayo Clinic Jacksonville Florida 32224
Northwestern University Hospital Chicago Illinois 60611
Loyola University Medical Center Maywood Illinois 60153
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
Massachusetts General Hospital Boston Massachusetts 02114
Veterans Administration Medical Center Albany New York 12208
The Icahn School of Medicine at Mount Sinai Hospital New York New York 10029
Sanford Health Fargo North Dakota 58122
Cleveland Clinic Cleveland Ohio 44195
Rhode Island Hospital Providence Rhode Island 02914
University of Virginia Health System Charlottesville Virginia 22908
Veterans Administration Medical Center Salem Virginia 24153

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03150420, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 18, 2020 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03150420 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →